These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Lorcainid--electrophysiologic examinations of a new anti-arrhythmia agent]. Gstöttner M; Ng CK; Gmeiner R Acta Med Austriaca; 1978; 5(4-5):137-8. PubMed ID: 756123 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacodynamics and pharmacokinetics of loracainide, a new anti-arrhythmia agent]. Meinertz T; Kasper W; Kersting F; Just H; Jähnchen E Verh Dtsch Ges Inn Med; 1978; (84):1477-9. PubMed ID: 84447 [No Abstract] [Full Text] [Related]
6. Flecainide--a new antiarrhythmic drug. Drug Ther Bull; 1984 Dec; 22(25):97-8. PubMed ID: 6510231 [No Abstract] [Full Text] [Related]
8. Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death. Shand DG; Pritchett EL; Hammill SC; Stargel WW; Wagner GS Ann N Y Acad Sci; 1982; 382():238-46. PubMed ID: 7044243 [No Abstract] [Full Text] [Related]
9. [Anti-arrhythmic action of perhexiline maleate in chronic coronary insufficiency]. Albanese MC; Feruglio GA Boll Soc Ital Cardiol; 1977; 22(9):1702-7. PubMed ID: 753352 [No Abstract] [Full Text] [Related]
15. [Anti-arrhythmic activity of quaternary derivatives of trimecaine in experimental ventricular arrhythmias]. Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP Biull Eksp Biol Med; 1982 Nov; 94(11):55-7. PubMed ID: 7150740 [No Abstract] [Full Text] [Related]
16. Electric cardioversion in treatment of atrial fibrillation. Zera E; Rydlewska-Sadowska W Pol Med J; 1969; 8(1):8-13. PubMed ID: 4238537 [No Abstract] [Full Text] [Related]
17. [Evaluation and use of the coronary and anti-arrhythmic drug Lidoflazin. Clinical, electrocardiographic, hemodynamic, and laboratory-chemical studies on 187 patients]. Lehmann HU; Ghabussi P; Hochrein H Med Welt; 1977 Feb; 28(8):386-90. PubMed ID: 321914 [No Abstract] [Full Text] [Related]
18. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease. Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484 [TBL] [Abstract][Full Text] [Related]
19. [1st experiences with the clinical use of a new antiarrhythmic agent: bunaftide]. Lotto A; Lomanto B; Bossi M Cardiol Prat; 1972; 23(2):123-33. PubMed ID: 5073277 [No Abstract] [Full Text] [Related]
20. [Anti-anginal and anti-arrhythmic properties of amiodarone]. Rizzon P; Biasco G; Di Biase M; Antonelli G Boll Soc Ital Cardiol; 1972; 17(7):413-7. PubMed ID: 4650836 [No Abstract] [Full Text] [Related] [Next] [New Search]